Navigation Links
Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Date:9/11/2009

THOUSAND OAKS, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Monday, Sept. 14, 2009, at the Grand Hyatt hotel in New York City, beginning at 12:00 p.m. Eastern Time. Amgen Chairman and CEO Kevin Sharer will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    John Shutter, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
2. Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
3. Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
4. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
5. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
6. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
7. Amgen to Present at the Cowen and Company Annual Healthcare Conference
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
10. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
11. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...LE, Md., Nov. 20 Novavax...s priced an underwritten public offering of 6,800,...ublic of $3.30 per share. The approximately $21 m...riting discounts and commissions, will be used for...P-based vaccines, internal research and developmen...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. D...quo;The Role of Process Analytical Technology (PAT...on December 1, 2009. , (P... Process Analytical Technology (PAT) in Green Chem..., Process Analytical Technology (PAT) case studies...
(Date:11/19/2009)... N.Y., Nov. 19 Dr. Mate Hidvegi, i...sponds to a press release issued on November 17 by...y for making false and self-serving statements abo..., Dr. Hidvegi stated from his office in Budapest, ...h on Avemar does not apply to AveULTRA, www.aveu...
(Date:11/19/2009)...RN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/ -...esources find that the leading driver of antibioti...road-spectrum activity against gram-positive and g...nisms that can cause nosocomial pneumonia, surveye...ily for agents that provide appropriate coverage a...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...ls, a,privately held biotechnology company develop...ular degeneration (AMD), announced today the appoi...z Sunness, M.D. to its Scientific,Advisory Board e... known macular degeneration specialist and pioneer...d macular degeneration, as,well as an internationa...
...Tissue Cooling During P...apeutics,(Amex: CXM ) and its operating unit Inne... developed a pelvic cooling catheter system called...d cooling during surgery,for prostate cancer (radi...plied in collaboration with renowned prostate surg...
...Newswire-FirstCall/ --,China Biologic Products, In...any"), one of the leading plasma-based pharmaceuti...PRC"), today announced that it will host a,confere...3, 2008, to,discuss the third quarter 2008 results... Executive Officer, and,Mr. Tristan Kuo, Chief Fin...
Other Biology Technology:Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board 2Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board 3Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 2Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 3Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 4Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 5Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 6Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 7Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 8China Biologic Products Announces Third Quarter 2008 Results Conference Call 2
(Date:11/23/2009).... , Not just birds, but also a few species o... at Princeton University in the U.S. and at the Ma...Germany studied the migratory behaviour of the lar...ilionidae" with the help of mathematical models. T...ll as long distances of various kinds of bats evol...
(Date:11/22/2009)... increase the likelihood of immune complications f...onal team of researchers reports in the November 2...the gene, called UGT2B17, is missing from the dono...ants have a significantly greater risk of a seriou...in which immune cells from the donor attack tissue...
(Date:11/20/2009)... scientific and technological frontiers. The Natio...rt that totals nearly $4.3 million for the diverse...American Recovery and Reinvestment Act of 2009. ,...investigation of solar phenomena. Philip R. Goode,...the capabilities of NJIT,s Big Bear Solar Observat...
Breaking Biology News(10 mins):We're off then: The evolution of bat migration 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Patient Advocates From All 50 States Gather in Nations Capitol to Meet With Lawmakers and Urge Passage of Comprehensive Health Care Reform 49881 1Patient Advocates From All 50 States Gather in Nations Capitol to Meet With Lawmakers and Urge Passage of Comprehensive Health Care Reform 49881 2Allscripts Clients Win Half of National E Prescriber of the Year Awards 49876 1Allscripts Clients Win Half of National E Prescriber of the Year Awards 49876 2Allscripts Clients Win Half of National E Prescriber of the Year Awards 49876 3Allscripts Clients Win Half of National E Prescriber of the Year Awards 49876 4Allscripts Clients Win Half of National E Prescriber of the Year Awards 49876 5TriLink BioTechnologies Inc Announces Sales and License Agreement With Glen Research Corporation for CleanAmp 28TM 29 Amidites 49872 1TriLink BioTechnologies Inc Announces Sales and License Agreement With Glen Research Corporation for CleanAmp 28TM 29 Amidites 49872 2
... biologists at Dartmouth, has found potentially da...angdian, the largest lake in the North China Plain...the people who live around it. , The researchers...ian, all at varying distances from major sources o...runoff, and sewage discharge. They found concentra...
...xactly come in boy and girl varieties, but they do... Duke University Medical Center shows that some of...s to how the sexes evolved in higher animals, incl... A team lead by Joseph Heitman, M.D. has isolated ... types of fungi, Phycomyces blakesleeanus, finding...
...ssociation of Water Companies (NAWC) held its annu...sident Bob Iacullo presented the 2007 Management I... member companies the opportunity to share innovat...ustry. This years second-prize award went to Unite... Marketing Program, a project developed in conjunc...
Other Biology News:Dartmouth researchers alarmed by levels of mercury and arsenic in Chinese freshwater ecosystem 2Evolution of the sexes: What a fungus can tell us 2United Water, in partnership with Stevens, wins Management Innovation Award 2
...he NOVOstar is an exciting product for cell-based ...y, cell-based assays required the use of expensive...y for scientists in the assay development stage. T...or cell-based assays as well as any other assay su...
Safety Glasses Dispensers from Terra Universal, Inc.
7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
Apparel Dispenser from Terra Universal, Inc.
Biology Products: